What is Mustan?
Mustane is an intravenous drug used to combat certain forms of blood and tissue cancer, including Hodgkin and non-Hodgkin's lymphoma. It is a very strong solution that is derived from mustard gas, so doctors are very careful when preparing and administering the drug to prevent accidental exposure or inhalation of the skin. When using alone or in combination with other chemotherapeutic drugs, most people experience significant relief from symptoms within a few weeks or months. Mustane effectively reduces the size of tumors and slows the spread of cancer in most patients.
Many chemotherapeutic drugs, including mubin, are classified as alkylating substances. They work by infiltrating the cores of cancer cells and chemically binding double strands of DNA firmly together. If the sources are not able to separate, the cell cannot start the process of mitosis or cell division. Tumors stop growing when new cells stop producing. In addition, existing cancer cells die and tumors begin with Zmened.
Mustane is usually provided intravenously at a hospital or clinic by a trained medical specialist. The drug can be devastating to healthy skin, fat or muscle tissue, so extreme measures are taken to ensure that the injection needle fully pierces a large vein into the arm. Most adult patients receive one or two injections of diluted chistan daily for a period of time, usually not more than about two weeks. The following treatment courses are carried out approximately every three to six weeks, depending on the patient's health and the tumor response.
It is possible to experience a number of side effects when using mustin. The most common immediate side effects are nausea and vomiting. Permanent side effects may include a reduction in the number of white and red blood cells, hair loss and lesions in the mouth. Because the drug deteriorates the immestem of Mune, patients and their doctors must take special measures to get behindprevented infections and allergic reactions. Mustain may adversely respond with other medicines, including over -the -counter medicines such as aspirin, so it is important that the doctor carefully examines the patient's current drugs before starting treatment.
During treatment, specialists carefully monitor the patient's health. If the number of blood cells is calculated too low, it may be necessary to reduce or stop doses. People who have been able to tolerate Mustin for several months usually begin to recover from their symptoms of cancer. Ongoing monitoring and frequent checks are important to ensure that cancer does not expand or deteriorate after treatment is completed.